Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RS Group well-positioned for market recovery, says Numis

(Sharecast News) - Numis has cut its estimates for industrial and electrical products maker RS Group but kept a 'buy' rating, saying that the company is well placed to benefit from gradually improving macro conditions. The broker forecasts a "modest market recovery" for RS Group in the current financial year ending 31 March 2025, but said that ongoing higher operating and finance costs has prompted it to slash earnings per share estimates by 8%.

Meanwhile, Numis reckons that RS will have seen a 50% "drop-through" of lost revenues to profit through this cycle due to cost inflation - compared with 25% in prior downturns - which is also "suggestive of a lagged response to managing a changing market dynamic".

However, the broker added: "When recovery materialises, we hope operational gearing can still work in reverse, particularly as ongoing cost pressure should be partly offset by identified cost savings."

Looking ahead, Numis said that, with S&P's closely following manufacturing PMIs now positive in the UK and US, "encouragingly lead indicators are now [...] steadily improving".

"The cycle appears to be turning and, as it does, we would expect RS to benefit. We retain a 'buy' rating on a reduced 1,050p target price (from 1,075p)."

The stock was up 1.5% at 721.5p by 1503 BST.

Share this article

Related Sharecast Articles

Thor posts strong first half, lowers full-year production guidance
(Sharecast News) - Gold explorers and miner Thor Explorations reported a solid first-half performance on Friday, although it lowered its full-year production guidance.
Trinity delays publication of scheme document for its takeover
(Sharecast News) - Trinity Exploration & Production announced a delay in the publication of the scheme document related to its recommended cash acquisition by Lease Operators on Friday.
Celadon confident in seeing through funding challenges
(Sharecast News) - Cannabis-based medicines specialist Celadon Pharmaceuticals updated the market on its financial position on Friday, amid ongoing challenges related to delays in expected funding.
Sound Energy inks bridge finance deal ahead of SEME sale completion
(Sharecast News) - Sound Energy has entered into a bridge financing facility agreement for up to £1.5m, it announced on Friday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.